5 Most Profitable Biotech Stocks To Invest In

4. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Q4 2023 Hedge Fund Shareholders: 60

Latest TTM Net Income: $8 billion

Bristol-Myers Squibb Company (NYSE:BMY) is one of the biggest healthcare companies in the world. Also a key player in the biotechnology industry, its cancer treatments have won global biotechnology awards, and to top things off, Bristol-Myers Squibb Company (NYSE:BMY) announced a $14 billion biotech acquisition in December 2023 for a company developing schizophrenia medication.

Insider Monkey scoured through 933 hedge funds for their fourth quarter of 2023 shareholdings and found that 60 were the firm’s investors. The largest Bristol-Myers Squibb Company (NYSE:BMY) investor is Josh Overdeck and David Siegel’s Two Sigma Advisors as it owns $456 million worth of shares.

Follow Bristol Myers Squibb Co (NYSE:BMY)